mortality/aging
|
• mice survive longer than ApcMin heterozygotes
|
neoplasm
|
• decreased adenoma and microadenoma compared with ApcMin heterozygotes without a change in intestinal crypt apoptosis and proliferation rates
|
digestive/alimentary system
|
• compared with ApcMin heterozygotes
|
|
• decreased adenoma and microadenoma compared with ApcMin heterozygotes without a change in intestinal crypt apoptosis and proliferation rates
|
cellular
|
• compared with ApcMin heterozygotes
|


Analysis Tools